Screening for 392 polymorphisms in 141 pharmacogenes

  • Authors:
    • Jason Yongha Kim
    • Hyun Sub Cheong
    • Tae‑Joon Park
    • Hee Jung Shin
    • Doo Won Seo
    • Han Sung Na
    • Myeon Woo Chung
    • Hyoung Doo Shin
  • View Affiliations

  • Published online on: April 30, 2014     https://doi.org/10.3892/br.2014.272
  • Pages: 463-476
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Pharmacogenomics is the study of the association between inter‑individual genetic differences and drug responses. Researches in pharmacogenomics have been performed in compliance with the use of several genotyping technologies. In this study, a total of 392 single‑nucleotide polymorphisms (SNPs) located in 141 pharmacogenes, including 21 phase I, 13 phase II, 18 transporter and 5 modifier genes, were selected and genotyped in 150 subjects using the GoldenGate assay or the SNaPshot technique. These variants were in Hardy‑Weinberg equilibrium (HWE) (P>0.05), except for 22 SNPs. Genotyping of the 392 SNPs revealed that the minor allele frequencies of 47 SNPs were <0.05, 105 SNPs were monomorphic and 22 variants were not in HWE. Also, based on previous studies, we predicted the association between the polymorphisms of certain pharmacogenes, such as cytochrome P450 2D6, cytochrome P450 2C9, vitamin K epoxide reductase complex, subunit 1, cytochrome P450 2C19, human leukocyte antigen, class I, B and thiopurine S‑methyltransferase, and drug efficacy. In conclusion, our study demonstrated the allele distribution of SNPs in 141 pharmacogenes as determined by high‑throughput screening. Our results may be helpful in developing personalized medicines by using pharmacogene polymorphisms.
View References

Related Articles

Journal Cover

July-August 2014
Volume 2 Issue 4

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kim JY, Cheong HS, Park TJ, Shin HJ, Seo DW, Na HS, Chung MW and Shin HD: Screening for 392 polymorphisms in 141 pharmacogenes. Biomed Rep 2: 463-476, 2014
APA
Kim, J.Y., Cheong, H.S., Park, T., Shin, H.J., Seo, D.W., Na, H.S. ... Shin, H.D. (2014). Screening for 392 polymorphisms in 141 pharmacogenes. Biomedical Reports, 2, 463-476. https://doi.org/10.3892/br.2014.272
MLA
Kim, J. Y., Cheong, H. S., Park, T., Shin, H. J., Seo, D. W., Na, H. S., Chung, M. W., Shin, H. D."Screening for 392 polymorphisms in 141 pharmacogenes". Biomedical Reports 2.4 (2014): 463-476.
Chicago
Kim, J. Y., Cheong, H. S., Park, T., Shin, H. J., Seo, D. W., Na, H. S., Chung, M. W., Shin, H. D."Screening for 392 polymorphisms in 141 pharmacogenes". Biomedical Reports 2, no. 4 (2014): 463-476. https://doi.org/10.3892/br.2014.272